<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04093037</url>
  </required_header>
  <id_info>
    <org_study_id>18CH115</org_study_id>
    <secondary_id>2018-A02257-48</secondary_id>
    <nct_id>NCT04093037</nct_id>
  </id_info>
  <brief_title>Analysis of the Diagnostic Performance of LacryDiag, a New Analyzer of the Ocular Surface in the Dry Eye</brief_title>
  <acronym>LACRYMOSA</acronym>
  <official_title>Analysis of the Diagnostic Performance of LacryDiag, a New &quot;All-in-one&quot; Non-contact Analyzer of the Ocular Surface in the Dry Eye. Study LACRYMOSA</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Saint Etienne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Saint Etienne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      LacryDiag is a new Conformity European (CE) marked diagnostic imaging device devoted to the
      analysis of the ocular surface. It is an &quot;all in one&quot; device that provides 4 data:
      non-invasive break-up time (Non-Invasive Break-Up-Time (NIBUT) without fluorescein eye drop);
      height of the Tear Meniscus (TM); an infrared image of the meibomian glands; a picture of the
      lacrimal film by interferometry. it's performance will be compare between in diagnosing dry
      eye syndrome with the standard clinical evaluation, in 80 patients suffering from dry eye
      diseases and followed at the consultation of the Ophthalmology department of the University
      Hospital of Saint-Etienne.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary purpose of this study is to compare the value of Break-Up-Time (BUT) between
      Non-Invasive Break-Up-Time (NIBUT) measured by LacryDiag and Standard Break-Up-Time (SBUT)
      measured by usual practice.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 14, 2019</start_date>
  <completion_date type="Anticipated">July 2021</completion_date>
  <primary_completion_date type="Anticipated">July 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>80 patients divided into 4 subgroups according to the value of manual Standard Break-Up-Time (SBUT):
0-5 seconds (very dry)
5-10 seconds (sec)
10-15 seconds (moderately dry)
15-20 seconds (normal)</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Break-Up-Time (BUT)</measure>
    <time_frame>Day: 1</time_frame>
    <description>Comparison of Break-Up-Time (BUT) measured by 2 methods : LacryDiag Non Invasive Break-Up Time (NIBUT) and manual Standard Break-Up Time (SBUT).
Measured in seconds by time#1: Non Invasive Break-Up Time (NIBUT) and time#3: Standard Break-Up Time (SBUT).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Standard Break-Up Time (SBUT)</measure>
    <time_frame>Day: 1</time_frame>
    <description>Comparison of Standard Break-Up Time (SBUT) between LacryDiag SBUT results and manual SBUT results. Measured in seconds.
Measured by time#3: Standard Break-Up Time (SBUT).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MicroInstillation Break-Up Time (MIBUT)</measure>
    <time_frame>Day: 1</time_frame>
    <description>Comparison of MicroInstillation Break-Up Time (MIBUT) between LacryDiag MIBUT results and manual MIBUT results.
Measured in seconds by time#1: Non Invasive Break-Up Time (NIBUT) and time#2: MicroInstillation Break-Up Time (MIBUT).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tear Meniscus (TM) height and Schirmer test</measure>
    <time_frame>Day: 1</time_frame>
    <description>Correlation between Tear Meniscus (TM) height (in millimeters) and Schirmer test (in millimeters).
Measured by time#1: Non Invasive Break-Up Time (NIBUT) and time#4: Schirmer test.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage loss of Meibomian Gland.</measure>
    <time_frame>Day: 1</time_frame>
    <description>Measured by time#1: Non Invasive Break-Up Time (NIBUT).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Thickness (in nanometer) and regularity of lacrimal film (type)</measure>
    <time_frame>Day: 1</time_frame>
    <description>Correlation between measure thickness (in nanometer) and regularity of lacrimal film (type).
Measured by time#1: Non Invasive Break-Up Time (NIBUT).</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Dry Eye</condition>
  <arm_group>
    <arm_group_label>Patient with dry eye disease</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patient with dry eye disease will be included. They will have:
Time #1: LacryDiag examination without dye
Time #2: MicroInstillation Break-Up Time (MIBUT) + Oxford score
Time #3: Standard Break-Up Time (SBUT)
Time #4: Schirmer test
Satisfaction questionnaire to the patient</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Time #1: Non Invasive Break-Up Time (NIBUT)</intervention_name>
    <description>A LacryDiag examination without dye will be realized. All measurements are made without contact. It's calculates the Non Invasive Break-Up Time (NIBUT), Tear Meniscus (TM) height (in millimeters) and number of Meibomian Gland.
These are different pictures taken with LacryDiag and analyzed.</description>
    <arm_group_label>Patient with dry eye disease</arm_group_label>
    <other_name>LacryDiag</other_name>
    <other_name>Complete diagnosis of dry eyes</other_name>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Time #2: MicroInstillation Break-Up Time (MIBUT) + Oxford score</intervention_name>
    <description>The MicroInstillation of fluorescein Break-Up Time (MIBUT) will be calculated by manual MIBUT and LacryDiag MIBUT.
The Oxford score will be calculated. It's used to clinically determine the severity of dry eyes with minimum score at 0 (none) and maximum score at 5 (very severity).</description>
    <arm_group_label>Patient with dry eye disease</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Time #3: Standard Break-Up Time (SBUT)</intervention_name>
    <description>The Standard Break-Up Time (SBUT) with fluorescein macroinstillation will be calculated by manual SBUT and LacryDiag SBUT.</description>
    <arm_group_label>Patient with dry eye disease</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Time #4: Schirmer test</intervention_name>
    <description>The Schirmer test will be performed. It consists of applying the end of a small strip of blotting paper behind the lower eyelid and examining the strip after 5 minutes.</description>
    <arm_group_label>Patient with dry eye disease</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Satisfaction questionnaire to the patient</intervention_name>
    <description>A satisfaction questionnaire to the patient will be completed at the end of the participation at the study.</description>
    <arm_group_label>Patient with dry eye disease</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Affiliates or beneficiaries of social security scheme

          -  With Dry eye of any cause, diagnosed with conventional means

          -  Signed informed consent

        Exclusion Criteria:

          -  Major blepharospasm

          -  Serious illness preventing participation according to investigator

          -  Allergy to fluorescein

          -  Pregnant or / and breastfeeding women

          -  Under guardianship, curatorship or safeguard of justice

          -  Unable to express their consent

          -  Person in emergency situation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gilles THURET, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU SAINT-ETIENNE</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gilles THURET, MD PhD</last_name>
    <phone>(0)4.77.12.77.96</phone>
    <phone_ext>+33</phone_ext>
    <email>Gilles.Thuret@chu-st-etienne.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Arnauld GARCIN, CRA</last_name>
    <phone>(0)4.77.12.02.86</phone>
    <phone_ext>+33</phone_ext>
    <email>Arnauld.Garcin@chu-st-etienne.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Chu Saint-Etienne</name>
      <address>
        <city>Saint-Étienne</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Gilles THURET, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Philippe GAIN, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marie Caroline TRONE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Caroline RONIN, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nicolas PERRILLAT - COLOMB, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>September 16, 2019</study_first_submitted>
  <study_first_submitted_qc>September 16, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 17, 2019</study_first_posted>
  <last_update_submitted>June 25, 2020</last_update_submitted>
  <last_update_submitted_qc>June 25, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 26, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Dry eye</keyword>
  <keyword>LacryDiag</keyword>
  <keyword>Fluorescein</keyword>
  <keyword>Break-Up Time (BUT)</keyword>
  <keyword>Schirmer test</keyword>
  <keyword>Lacrimal film</keyword>
  <keyword>Oxford score</keyword>
  <keyword>Meibomian Gland</keyword>
  <keyword>Tear Meniscus (TM)</keyword>
  <keyword>Non Invasive Break-Up Time (NIBUT)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Keratoconjunctivitis Sicca</mesh_term>
    <mesh_term>Dry Eye Syndromes</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

